Latest IDEXX Laboratories Inc. Stories
-- Achieves full-year normalized organic revenue growth of 10%, driven by 11% normalized organic growth in CAG Diagnostics recurring revenue WESTBROOK, Maine, Jan.
WESTBROOK, Maine, Jan. 23, 2015 /PRNewswire/ -- IDEXX Laboratories, Inc.
IDEXX continues to build upon its highly innovative test menu, expanding veterinarians' medical capability and supporting long-term growth in IDEXX recurring diagnostic revenues WESTBROOK,
-- Fourth quarter placements of Catalyst® and premium hematology analyzers in total increased 21% WESTBROOK, Maine, Jan. 14, 2015 /PRNewswire/ -- IDEXX Laboratories, Inc.
WESTBROOK, Maine, Jan. 5, 2015 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the 33(rd) Annual J.P. Morgan Healthcare Conference.
Chairman and CEO Jonathan Ayers will have the honor of ringing the Closing Bell at NASDAQ on Tuesday, December 16--a first for the company and for Maine WESTBROOK, Maine, Dec.
- Delivers 11% normalized organic revenue growth and $1.05 Adjusted EPS, driven by strong growth in all business segments and regions including 12% normalized organic growth in CAG Diagnostics recurring
- IDEXX selects UPS to support its US all-direct product distribution capability, providing IDEXX a cost effective, logistics solution for the entire continental US WESTBROOK,
WESTBROOK, Maine, July 31, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) will host its 2014 Analyst Day on August 7-8, 2014 at its corporate headquarters in Westbrook, Maine.
- Delivers 9% organic revenue growth and $1.10 EPS, driven by double-digit gains in Companion Animal Group Diagnostics recurring revenues WESTBROOK, Maine, July 25, 2014 /PRNewswire/ -- IDEXX
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.